Skip to main content

Table 1 Baseline demographics and clinical characteristics of the RA patients included in the study

From: Enhanced activity of NLRP3 inflammasome in peripheral blood cells of patients with active rheumatoid arthritis

 

RA patients (n = 23)

Demographics

 Age, years

52.6 (2.8)*

 Gender, % female

77

Clinical characteristics

 

 Disease duration, years

4.7 (1)

 Rheumatoid factor and/or anti-CCP positive, %

30

 Disease activity score in 28 joints

6 (0.2)

 Swollen (28)

8.7 (1.2)

 Tender (28)

10.8 (1.7)

 C-reactive protein, mg/dL

2.4 (1.3)

 Erythrocyte sedimentation rate, mm/h

39.8 (7.3)

Treatments

 Naïve to treatment, n/total (%)

13/23 (56 %)

 Methotrexate, n/total (%)

7/23 (30)

 Methotrexate dose, mg/week

17.1 (1.5)

 Leflunomide, n/total (%)

3/23 (13)

 Biologic agents, n/total (%)

4/23 (17)

 Glucocorticoids, n/total (%)

5/23 (22)

 Glucocorticoid dose, mg/day

8.2 (3.3)

  1. *Except where indicated otherwise, values are the mean (standard error of the mean). anti-CCP anti-cyclic citrullinated peptide